Evaluation of the Endorsement of the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) Statement on the Quality of Published Systematic Review and Meta-Analyses
暂无分享,去创建一个
Walter Ricciardi | Stefania Boccia | S. Boccia | E. Leoncini | W. Ricciardi | Nikola Panic | Emanuele Leoncini | Giulio de Belvis | N. Panic | Giulio de Belvis
[1] David Moher,et al. An international registry of systematic-review protocols , 2011, The Lancet.
[2] David Moher,et al. From QUOROM to PRISMA: A Survey of High-Impact Medical Journals' Instructions to Authors and a Review of Systematic Reviews in Anesthesia Literature , 2011, PloS one.
[3] D. Altman,et al. Effect of using reporting guidelines during peer review on quality of final manuscripts submitted to a biomedical journal: masked randomised trial , 2011, BMJ : British Medical Journal.
[4] J. Poorolajal,et al. Quality of Cohort Studies Reporting Post the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement , 2011, Epidemiology and health.
[5] I. Olkin,et al. Improving the quality of reports of meta‐analyses of randomised controlled trials: the QUOROM statement , 2000, Revista espanola de salud publica.
[6] H S Sacks,et al. Meta-analysis: an update. , 1996, The Mount Sinai journal of medicine, New York.
[7] David Moher,et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews , 2007, BMC medical research methodology.
[8] P. Tugwell,et al. A Comparison of the Quality of Cochrane Reviews and Systematic Reviews Published in Paper-Based Journals , 2002, Evaluation & the health professions.
[9] I. Olkin,et al. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement , 1999, The Lancet.
[10] S. Pocock,et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration , 2007, PLoS medicine.
[11] Jeremy Grimshaw,et al. AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews. , 2009, Journal of clinical epidemiology.
[12] Robert L Kane,et al. Reporting in randomized clinical trials improved after adoption of the CONSORT statement. , 2007, Journal of clinical epidemiology.
[13] P. Masand,et al. The impact of the CONSORT statement on reporting of randomized clinical trials in psychiatry. , 2009, Contemporary clinical trials.
[14] C. Mulrow. The medical review article: state of the science. , 1987, Annals of internal medicine.
[15] E. Romagnoli,et al. Compliance with QUOROM and quality of reporting of overlapping meta-analyses on the role of acetylcysteine in the prevention of contrast associated nephropathy: case study , 2006, BMJ : British Medical Journal.
[16] C. Paul,et al. CONSORT adoption and quality of reporting of randomized controlled trials: a systematic analysis in two dermatology journals , 2009, The British journal of dermatology.
[17] Richard Horton,et al. Putting clinical trials into context , 2005, The Lancet.
[18] J. Ioannidis,et al. The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration , 2009, Annals of Internal Medicine [serial online].
[19] D. Rennie,et al. How to report randomized controlled trials. The CONSORT statement. , 1996, JAMA.
[20] Sharon E. Straus,et al. Interventions to improve the use of systematic reviews in decision-making by health system managers, policy makers and clinicians. , 2012, The Cochrane database of systematic reviews.
[21] David Moher,et al. Epidemiology and Reporting Characteristics of Systematic Reviews , 2007, PLoS medicine.